日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

GLUD1 supports ovarian cancer progression by counteracting anoikis via ARAF/MEK/ERK signaling.

GLUD1 通过 ARAF/MEK/ERK 信号通路对抗细胞凋亡,从而促进卵巢癌的进展。

Feng Huolun, Chen Yanzhen, Wu Geyan, Zhang Zhentao, Lai Hongkun, Yang Changnian, Zhang Shaofen, Lin Yongqing, Liu Yingqi, Ye Haiyan, Wu Shanshan, Cao Lixue

Prognostic value of lymphocyte-to-monocyte ratio for breast cancer: a systematic review and meta-analysis

淋巴细胞与单核细胞比值对乳腺癌预后的价值:系统评价和荟萃分析

Zhu, Linying; Qiao, Jinfang; Yang, Changnian; Ruan, Xiaoyi; Wu, Shanshan